LDLuiz Henrique Junqueira Dieckmann

Luiz Henrique Junqueira Dieckmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luiz Henrique Junqueira Dieckmann has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Therapeutic Overlap Between Bipolar Disorder and Migraine: A Systematic Review of Pharmacological Trials

    by Michel Haddad, Luiz Henrique Junqueira Dieckmann, Naielly Rodrigues da Silva, Paula Dieckmann, Thiago Wendt Viola, Jair de Jesus Mari

    Background/Objectives: Migraine is markedly more prevalent among individuals with bipolar disorder (BD) than in the general population. The two disorders share overlapping pathophysiological mechanisms, including neuroinflammation, oxidative stress, and genetic vulnerability. However, the potential bidirectional efficacy of pharmacological agents approved for one condition on the other remains unclear. This study aimed to evaluate cross-disorder pharmacological efficacy between migraine and bipolar disorder. Methods: We systematically searched Medline and the Cochrane Central Register of Controlled Trials (PROSPERO registration: CRD420251130780) for randomized controlled trials (RCTs) assessing (1) concurrent treatment effects in comorbid BD–migraine samples, (2) efficacy of migraine treatments in BD, or (3) efficacy of BD treatments in migraine. Searches included guideline-recommended drugs for either disorder, without language or date restrictions. Results: A total of 32 RCTs met the inclusion criteria. Fifteen studies evaluated migraine drugs in BD, and sixteen evaluated BD drugs in migraine. No RCTs were identified that simultaneously assessed both conditions within the same sample. Valproate was the only agent demonstrating consistent, replicated efficacy in both conditions, supporting true cross-disorder benefit. Haloperidol and chlorpromazine showed limited evidence for acute anti-migraine efficacy, based solely on placebo-controlled studies, whereas all other guideline-recommended BD drugs lacked evidence of benefit for migraine. Conversely, topiramate, while effective for migraine, was inferior to valproate in BD outcomes, and lamotrigine was effective for BD only when compared with placebo. Conclusions: Valproate remains the sole pharmacological agent with robust evidence of bidirectional efficacy in migraine and BD. Most other guideline-recommended medications show disorder-specific effects, highlighting the need for integrative trials addressing pharmacological overlap in comorbid migraine–BD samples.


  • Open Access

    Correlation between levels of perceived stress and depressive symptoms in the functional disability of patients with fibromyalgia

    by Luiz Gustavo Rachid Fernandes, Carolyn Maria de Geus Wenceslau, André Amaro Mamédio dos Santos, Diogo Von Gaevernitz Lima, Luiz Henrique Junqueira Dieckmann, Michel Haddad, Fabiana Postiglione Mansani, Marcelo Derbli Schafranski

    The aim of this study was to evaluate the factors that are most correlated with the levels of functional disability in patients with fibromyalgia.


  • Effects of biperiden on the treatment of cocaine/crack addiction: A randomised, double-blind, placebo-controlled trial

    by Luiz Henrique Junqueira Dieckmann, Anna Carolina Ramos, Eroy Aparecida Silva, Luis Pereira Justo, Pamela Sabioni, Iracema Francisco Frade, Altay Lino de Souza, José Carlos Fernandes Galduróz


  • Open Access

    Factors associated with depressive symptoms in a sample of Brazilian medical students

    by Paula Natalie Arraes Guedes Macedo, Luciana Loureiro Nardotto, Luiz Henrique Junqueira Dieckmann, Yngrid Dieguez Ferreira, Barbara Arraes Guedes Macedo, Maria Aparecida Pedrosa dos Santos, Mario Alfredo De Marco

    OBJECTIVES: 1 - Verify the prevalence of depressive symptoms in first to fourth-year medical students using the Beck Depression Inventory (BDI). 2 - Establish correlations between target factors and higher or lower BDI scores. 3 - Investigate the relationship between the prevalence of depressive symptoms and the demand for psychological care offered by the Centro Universitário Lusíada. METHOD: Cross-sectional study of 290 first to fourth-year medical students; implementation of the BDI, socio-demographic survey, and evaluation of satisfaction with progress. RESULTS: The study sample was 59% female and 41% male. Mean BDI was 6.3 (SD 5.8). Overall prevalence of depressive symptoms was 23.1%. The following associations were statistically significant (p<0.05): among students for whom the course failed to meet original expectations, who were dissatisfied with the course, or who came from the interior of the State (20.5%, 12.5%, and 24.4% of the total sample, respectively), for 40%, 36.1% and 36.4%, respectively, the BDI was consistent with some degree of depression. CONCLUSION: The study showed that there is higher prevalence of depressive symptoms in medical students than in the general population


  • Open Access

    Estratégia de manejo para a disfunção sexual induzida por antipsicóticos: descrição de um relato de caso

    by Luciana Vargas Nunes, Luiz Henrique Junqueira Dieckmann, Fernando Sargo Lacaz, Rodrigo Affonseca Bressan, Jair de Jesus Mari

    Universidade Federal de São Paulo (UNIFESP) Departamento de Psiquiatria Programa de EsquizofreniaUniversidade Federal de São Paulo (UNIFESP) Departamento de PsiquiatriaUNIFESP, Depto. de Psiquiatria Programa de EsquizofreniaUNIFESP, Depto. de PsiquiatriaSciEL